Skip to search formSkip to main contentSkip to account menu

moguisteine

Known as: 2-(2-methoxyphenoxy)methyl-3-ethoxycarbonylacetyl-1,3-thiazolidine, 3-Thiazolidinepropanoic acid, 2-((2-methoxyphenoxy)methyl)-beta-oxo-, ethyl ester, (+-)-, ethyl 2-((2-methoxyphenoxy)methyl)-beta-oxothiazolidine-3-propanoate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
The aim of the present study was to investigate the relation between bronchoconstriction and cough induced by methacholine (Mch… 
Review
2002
Review
2002
Editor—Schroeder and Fahey are right to urge caution in interpreting the results of their systematic review on cough medicines… 
1998
1998
We have studied the effects of moguisteine, a new non-narcotic, peripherally acting antitussive compound, on tracheobronchial… 
1996
1996
Cough is a common symptom of respiratory diseases associated with irritation or inflammation of the airways, and symptomatic… 
1996
1996
The antitussive effect of the R‐(+)‐ and S‐(‐)‐enantiomers of moguisteine were evaluated in comparison with the racemate in cough… 
1996
1996
Moguisteine (R,S(+/-)-2-(2-methoxyphenoxy)-methyl-3-ethoxycarbonylacetyl-1,3-t hiazolidine, CAS 119637-67-1), a new peripheral… 
1995
1995
The synthesis of a novel class of antitussive agents is described. The compounds were examined for antitussive activity in guinea… 
1995
1995
SummaryWe studied the pharmacokinetics of moguisteine, a racemic non-narcotic peripheral antitussive drug, in 12 healthy male… 
1993
1993
This completely randomised, double-blind, placebo-controlled, multicentre trial was carried out to evaluate the antitussive…